Arizona State Retirement System increased its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 1.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 176,736 shares of the conglomerate’s stock after purchasing an additional 2,519 shares during the quarter. Arizona State Retirement System’s holdings in Danaher were worth $33,665,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. High Note Wealth LLC lifted its position in Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares during the period. First Command Advisory Services Inc. raised its stake in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after buying an additional 47 shares during the last quarter. GW&K Investment Management LLC lifted its holdings in shares of Danaher by 8.4% in the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after buying an additional 47 shares during the period. Kestra Private Wealth Services LLC boosted its stake in shares of Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after buying an additional 48 shares during the last quarter. Finally, Gabelli Funds LLC grew its holdings in Danaher by 0.3% during the fourth quarter. Gabelli Funds LLC now owns 18,981 shares of the conglomerate’s stock worth $4,345,000 after acquiring an additional 50 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.
Danaher Price Performance
Shares of DHR traded down $2.43 during mid-day trading on Tuesday, hitting $205.23. 3,276,292 shares of the company were exchanged, compared to its average volume of 4,466,724. The stock has a market cap of $144.28 billion, a price-to-earnings ratio of 36.45, a price-to-earnings-growth ratio of 2.59 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a 50 day moving average of $202.03 and a 200-day moving average of $192.15. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.
Analyst Ratings Changes
A number of research analysts have weighed in on DHR shares. Evercore reiterated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Royal Bank Of Canada lifted their price target on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. Piper Sandler initiated coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Guggenheim cut their price objective on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Finally, Stifel Nicolaus reduced their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $228.91.
Get Our Latest Stock Analysis on DHR
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
